Increasing demand for IVF, expanding fertility clinics, and innovation in reproductive technologies drive sustained growth at a 7.0% CAGR
Delray Beach, FL, April 02, 2026 (GLOBE NEWSWIRE) — The global Assisted Reproductive Technology (ART) market is entering a high-growth phase, driven by rising infertility rates, evolving patient needs, and continuous innovation in fertility treatments. Valued at US$4.02 billion in 2024, the market is projected to grow to US$4.29 billion in 2025 and reach US$6.02 billion by 2030, registering a robust CAGR of 7.0%.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=91934243
What is fueling this rapid expansion, and why does it matter now?
Increasing infertility levels linked to stress, lifestyle changes, and underlying medical conditions are significantly accelerating demand for advanced reproductive solutions. As more individuals and couples seek effective fertility treatments, ART technologies are becoming central to modern healthcare systems worldwide.
How is technology reshaping outcomes in this space?
Breakthroughs such as preimplantation genetic testing (PGT), embryo cryopreservation, and enhanced in-vitro fertilization (IVF) techniques are improving success rates and clinical efficiency. These innovations are not only increasing patient confidence but also expanding the addressable market by enabling treatment for complex infertility cases, including advanced maternal age and male-factor infertility.
However, what challenges could impact growth?
Despite strong momentum, the ART market faces constraints from ethical and regulatory complexities, including legal restrictions, high treatment costs, and ongoing debates surrounding embryo handling and surrogacy. These factors vary significantly across regions, influencing market accessibility and adoption rates.
Request Sample Pages : https://www.marketsandmarkets.com/requestsampleNew.asp?id=91934243
Where are the most significant opportunities emerging?
Government support, increasing awareness of fertility treatments, and shifting societal perceptions toward assisted reproduction are creating favorable conditions for market expansion. Additionally, improving healthcare infrastructure and rising disposable incomes in developing economies are unlocking new growth avenues.
Which segments are leading the market today?
- By Type: Equipment dominates the ART market, supported by its critical role in procedures such as IVF, embryo culture, and cryopreservation. Advanced instruments including incubators, micromanipulators, and imaging systems are essential for ensuring precision, automation, and improved outcomes in fertility labs. The growing number of fertility clinics and increasing procedural complexity further reinforce this segment’s leadership.
- By Technology: IVF remains the cornerstone of ART, accounting for the largest market share due to its high success rates and broad applicability. Continuous improvements such as time-lapse imaging and genetic screening are positioning IVF as the preferred treatment globally. Rising infertility rates and delayed conception trends are further accelerating its adoption.
- By Care Settings: Fertility clinics lead the market, offering comprehensive ART services including IVF, intrauterine insemination (IUI), and fertility preservation. Equipped with advanced technologies and specialized expertise, these clinics deliver higher success rates, making them the primary choice for patients. The proliferation of private fertility centers and government-backed initiatives is further driving this segment.
Why is Asia-Pacific emerging as a high-growth region?
The region is projected to witness the fastest growth over the next five years, driven by increasing infertility rates, improved healthcare infrastructure, and growing awareness of ART solutions. Countries such as India, Thailand, and Spain are becoming hubs for medical tourism, offering cost-effective fertility treatments compared to Western markets. Rising middle-class populations and greater acceptance of fertility preservation methods are expected to sustain long-term growth.
Who are the key players shaping the ART market?
Leading companies are leveraging both organic and inorganic strategies including product launches, partnerships, acquisitions, and geographic expansions to strengthen their market positions.
Prominent players include CooperSurgical Inc. (US), FUJIFILM Irvine Scientific (Japan), Vitrolife (Sweden), Hamilton Thorne (US), Cook Medical Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea BIOMEDX (Australia), Thermo Fisher Scientific Inc. (US), LENUS Pharma GesmbH (Austria), Zita West (UK), Kitazato Corporation (Japan), Exeltis USA, Inc. (US), Vitabiotics Ltd (UK), FertiPro NV (Belgium), and AdvaCare Pharma (US).
Why This Matters Now:
As infertility becomes a growing global health concern, ART is transitioning from a niche solution to a mainstream medical necessity. For healthcare providers, investors, and policymakers, this market represents a critical intersection of innovation, demand, and long-term societal impact.
For more information, Inquire Now!
Discover Connected Healthcare Market Opportunities:
In Vitro Fertilization Market
In Vitro Diagnostics Market
Clinical Trial Services Market
Immunoassay Market
Biologics Safety Testing Market
Get access to the latest updates on Assisted Reproductive Technology Companies and Assisted Reproductive Technology Market Size
CONTACT: About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter , LinkedIn and Facebook . Contact: Mr. Rohan Salgarkar MarketsandMarkets™ INC. 1615 South Congress Ave. Suite 103, Delray Beach, FL 33445 USA: +1-888-600-6441 Email: sales@marketsandmarkets.com Visit Our Website: https://www.marketsandmarkets.com/